Our research focuses on the structure and function of medically important proteins, and structure-based design of inhibitors for treatment of human diseases. The current topics include enzymatic and structural characterization of cyclic nucleotide phosphodiesterases (PDEs), structure-based design of PDE selective inhibitors, and discovery of novel metallo-β-lactamase (MBL) inhibitors to fight against superbugs.